{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T06:17:32Z","timestamp":1766902652100},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,15]],"date-time":"2011-11-15T00:00:00Z","timestamp":1321315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s13277-011-0263-5","type":"journal-article","created":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T01:39:47Z","timestamp":1321234787000},"page":"207-214","source":"Crossref","is-referenced-by-count":15,"title":["COX-2 and survivin reduction may play a role in berberine-induced apoptosis in human ductal breast epithelial tumor cell line"],"prefix":"10.1007","volume":"33","author":[{"given":"Yaghub","family":"Pazhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahin","family":"Ahmadian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader","family":"Javadifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahshid","family":"Shafiezadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,15]]},"reference":[{"issue":"1","key":"263_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jep.2009.08.009","volume":"126","author":"J Tang","year":"2009","unstructured":"Tang J, Feng YB, Tsao S, Wang N, Curtain R, Wang YW. Berberine and Coptidis Rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol. 2009;126(1):5\u201317.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"263_CR2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00204-005-0014-8","volume":"80","author":"JM Hwang","year":"2006","unstructured":"Hwang JM, Kuo HC, Tseng TH, Liu JY, Chu CY. Berberine induces apoptosis through a mitochondria\/caspases pathway in human hepatoma cells. Arch Toxicol. 2006;80(2):62\u201373.","journal-title":"Arch Toxicol"},{"issue":"1","key":"263_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3748\/wjg.v12.i1.21","volume":"12","author":"JP Lin","year":"2006","unstructured":"Lin JP, Yang JS, Lee JH, Hsieh WT, Chung JG. Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World J Gastroenterol. 2006;12(1):21\u20138.","journal-title":"World J Gastroenterol"},{"issue":"13","key":"263_CR4","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1158\/0008-5472.CAN-08-0511","volume":"68","author":"MK Pandey","year":"2008","unstructured":"Pandey MK, Sung B, Kunnumakkara AB, Sethi G, Chaturvedi MM, Aggarwal BB. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res. 2008;68(13):5370\u20139.","journal-title":"Cancer Res"},{"issue":"8","key":"263_CR5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1471-4914(02)02375-4","volume":"8","author":"RZ Orlowski","year":"2002","unstructured":"Orlowski RZ, Baldwin Jr AS. NF-\u03baB as a therapeutic target in cancer. Trends Mol Med. 2002;8(8):385\u20139.","journal-title":"Trends Mol Med"},{"issue":"2","key":"263_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0304-3835(95)03809-B","volume":"93","author":"CL Kuo","year":"1995","unstructured":"Kuo CL, Chou CC, Yung BY. Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett. 1995;93(2):193\u2013200.","journal-title":"Cancer Lett"},{"key":"263_CR7","doi-asserted-by":"crossref","unstructured":"Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular,and molecular biology. 2000;145\u201382.","DOI":"10.1146\/annurev.biochem.69.1.145"},{"issue":"2","key":"263_CR8","first-page":"46","volume":"21","author":"MT Yip-Schneider","year":"2000","unstructured":"Yip-Schneider MT, Barnard DS, Billings SD, Cheng L, Heilman DK, Lin A, et al. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis. 2000;21(2):46\u2013139.","journal-title":"Carcinogenesis"},{"issue":"19","key":"263_CR9","first-page":"730","volume":"61","author":"AH Klimp","year":"2001","unstructured":"Klimp AH, Hollema H, Kempinga C, Van der Zee AGJ, De Vries EGE, Daemen T. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res. 2001;61(19):730.","journal-title":"Cancer Res"},{"issue":"5","key":"263_CR10","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/S0003-4975(02)04022-5","volume":"74","author":"SS Qadri","year":"2002","unstructured":"Qadri SS, Wang JH, Redmond KC, O\u2019Donnell AF, Aherne T, Redmond HP. The role of COX-2 inhibitors in lung cancer. Ann Thorac Surg. 2002;74(5):1648\u201352.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"263_CR11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1054\/bjoc.2000.1607","volume":"84","author":"WK Leung","year":"2001","unstructured":"Leung WK, To KF, Ng YP, Lee TL, Lau JYW, Chan FKL, et al. Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer. Brit J Cancer. 2001;84(3):335\u20139.","journal-title":"Brit J Cancer"},{"key":"263_CR12","doi-asserted-by":"crossref","unstructured":"Khan MN, Lee YS. Cyclooxygenase inhibitors: scope of their use and development in cancer chemotherapy. Med Res Rev. 2009. doi: 10.1002\/med.20182 .","DOI":"10.1002\/med.20182"},{"issue":"3","key":"263_CR13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgp014","volume":"30","author":"A Greenhough","year":"2009","unstructured":"Greenhough A, Smartt HJM, Moore AE, Roberts HR, Williams AC, Paraskeva C, et al. The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis. 2009;30(3):377\u201386.","journal-title":"Carcinogenesis"},{"issue":"Suppl 5","key":"263_CR14","first-page":"57","volume":"56","author":"PC Konturek","year":"2005","unstructured":"Konturek PC, Kania J, Burnat G, Hahn EG, Konturek SJ. Prostaglandins as mediators of COX-2 derived carcinogenesis in gastrointestinal tract. J Physiol Pharmacol. 2005;56 Suppl 5:57\u201373.","journal-title":"J Physiol Pharmacol"},{"issue":"6","key":"263_CR15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0092-8674(94)90266-6","volume":"78","author":"C Nathan","year":"1994","unstructured":"Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell. 1994;78(6):915\u20138.","journal-title":"Cell"},{"issue":"1","key":"263_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/bjc.1995.274","volume":"72","author":"LL Thomsen","year":"1995","unstructured":"Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase activity in human breast cancer. Brit J Cancer. 1995;72(1):41\u20134.","journal-title":"Brit J Cancer"},{"issue":"3","key":"263_CR17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0002-9440(10)63876-X","volume":"162","author":"F Cianchi","year":"2003","unstructured":"Cianchi F, Cortesini C, Fantappi\u00e8 O, Messerini L, Schiavone N, Vannacci A, et al. Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. Am J Pathol. 2003;162(3):793\u2013801.","journal-title":"Am J Pathol"},{"issue":"9","key":"263_CR18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.lfs.2006.03.010","volume":"79","author":"XQ Tang","year":"2006","unstructured":"Tang XQ, Yu HM, Zhi JL, Cui Y, Tang EH, Feng JQ, et al. Inducible nitric oxide synthase and cyclooxgenase-2 mediate protection of hydrogen peroxide preconditioning against apoptosis induced by oxidative stress in PC12 cells. Life Sci. 2006;79(9):870\u20136.","journal-title":"Life Sci"},{"issue":"4","key":"263_CR19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/(SICI)1096-9098(199904)70:4<222::AID-JSO5>3.0.CO;2-G","volume":"70","author":"M Kojima","year":"1999","unstructured":"Kojima M, Morisaki T, Tsukahara Y, Uchiyama A, Matsunari Y, Mibu R, et al. Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J Surg Oncol. 1999;70(4):222\u20139.","journal-title":"J Surg Oncol"},{"issue":"2","key":"263_CR20","first-page":"334","volume":"58","author":"S Ambs","year":"1998","unstructured":"Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 1998;58(2):334\u201341.","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"263_CR21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0014-5793(98)00844-8","volume":"433","author":"YH Shen","year":"1998","unstructured":"Shen YH, Wang XL, Wilcken DE. Nitric oxide induces and inhibits apoptosis through different pathways. FEBS Lett. 1998;433(1\u20132):125\u201331.","journal-title":"FEBS Lett"},{"issue":"1","key":"263_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1005963400984","volume":"17","author":"PK Lala","year":"1998","unstructured":"Lala PK. Significance of nitric oxide in carcinogenesis, tumor progression and cancer therapy. Cancer Metast Rev. 1998;17(1):1\u20136.","journal-title":"Cancer Metast Rev"},{"issue":"2","key":"263_CR23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0463.2009.02569.x","volume":"118","author":"K Zafirellis","year":"2010","unstructured":"Zafirellis K, Zachaki A, Agrogiannis G, Gravani K. Inducible nitric oxide synthase expression and its prognostic significance in colorectal cancer. APMIS. 2010;118(2):115\u201324.","journal-title":"APMIS"},{"issue":"1\u20132","key":"263_CR24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11010-005-9114-2","volume":"290","author":"E Atik","year":"2006","unstructured":"Atik E, Ergin M, Erdo\u01e7an S, Tuncer I. Inducible nitric oxide synthase and apoptosis in human B cell lymphomas. Mol Cell Biochem. 2006;290(1\u20132):205\u20139.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"263_CR25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2006.12.020","volume":"249","author":"MJ Duffy","year":"2007","unstructured":"Duffy MJ, O'Donovan N, Brennan DJ, Gallagher WM, Ryan BM. Survivin: a promising tumor biomarker. Cancer Lett. 2007;249(1):49\u201360.","journal-title":"Cancer Lett"},{"issue":"2","key":"263_CR26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bjc.6602932","volume":"94","author":"N Barnes","year":"2006","unstructured":"Barnes N, Haywood P, Flint P, Knox WF, Bundred NJ. Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence. Br J Cancer. 2006;94(2):253\u20138.","journal-title":"Br J Cancer"},{"issue":"7","key":"263_CR27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ctrv.2009.05.003","volume":"35","author":"BM Ryan","year":"2009","unstructured":"Ryan BM, O'Donovan N, Duffy MJ. Survivin: a new target for anti-cancer therapy. Cancer Treat Rev. 2009;35(7):553\u201362.","journal-title":"Cancer Treat Rev"},{"issue":"25","key":"263_CR28","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.3748\/wjg.v11.i25.3830","volume":"11","author":"GY Wang","year":"2005","unstructured":"Wang GY, Ji B, Wang X, Gu JH. Anti-cancer effect of iNOS inhibitor and its correlation with angiogenesis in gastric cancer. World J Gastroenterol. 2005;11(25):3830\u20133.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"263_CR29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0014-2964(79)90139-7","volume":"15","author":"I Keydar","year":"1979","unstructured":"Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, et al. Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer. 1979;15(5):659\u201370.","journal-title":"Eur J Cancer"},{"issue":"8","key":"263_CR30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1042\/CBI20100832","volume":"35","author":"L Yan","year":"2011","unstructured":"Yan L, Yinghui T, Bo Y, Gang Z, Xian X, Lu Z. Effect of calcitonin gene-related peptide on nitric oxide production in osteoblasts: an experimental study. Cell Biol Int. 2011;35(8):757\u201365.","journal-title":"Cell Biol Int"},{"issue":"5","key":"263_CR31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-3623(97)00012-8","volume":"29","author":"M Holstad","year":"1997","unstructured":"Holstad M, Jansson L, Sandler S. Inhibition of nitric oxide formation by aminoguanidine: an attempt to prevent insulin-dependent diabetes mellitus. Gen Pharmacol. 1997;29(5):697\u2013700.","journal-title":"Gen Pharmacol"},{"issue":"8","key":"263_CR32","first-page":"815","volume":"2","author":"JA Crowell","year":"2003","unstructured":"Crowell JA, Steele VE, Sigman CC, Fay JR. Is inducible nitric oxide synthase a target for chemoprevention? Mol Cancer Ther. 2003;2(8):815\u201323.","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"263_CR33","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3748\/wjg.15.1065","volume":"15","author":"NA Mohamad","year":"2009","unstructured":"Mohamad NA, Cricco GP, Sambuco LA, Croci M, Medina VA, Gutierrez AS, et al. Aminoguanidine impedes human pancreatic tumor growth and metastasis development in nude mice. World J Gastroenterol. 2009;15(9):1065\u201371.","journal-title":"World J Gastroenterol"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-011-0263-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-011-0263-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-011-0263-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T13:39:32Z","timestamp":1560951572000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-011-0263-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,15]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["263"],"URL":"https:\/\/doi.org\/10.1007\/s13277-011-0263-5","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,15]]}}}